Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose Symbicort, budesonide, formoterol, or placebo on sputum glucocorticoid receptor activity in COPD
2010-020440-35Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Aug 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide and formoterol in chronic obstructive pulmonary disease (COPD) (5 arms), sponsored by Imperial College London. Started Aug 2011; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-020440-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020440-35.